tbuckley/cabot-search huggingface dataset:
Incorporation of O-Glycopeptides into FVIII Decreases Its Immunogenicity
Authors: Meng-Ni Fan, Matthew Chrzanowski, Amber Vander Kooi, Tangliang Shen, Rodney M. Camire, Xiaohe Cai, Ting-Yen Chao, Junping Zhang, Barbara A. Konkle, Carol H. Miao, Lei Li, Weidong Xiao
Journal: Blood (2023)
Comparison of the Enzymatic and Cellular Profiles of Clinical JAK2 Inhibitors for the Treatment of Myelofibrosis
Authors: Hamza Celik, Maryanne Covington, Katherine Drake, Kamna Katiyar, Alex Margulis, Amanda Smith, Gaurang Trivedi, Brittney Wass, Guofeng Zhang, Nina Zolotarjova, Sunkyu Kim, Ricardo Macarrón
Journal: Blood (2023)
Lisocabtagene Maraleucel in Relapsed/Refractory Large B-Cell Lymphoma: Real World Analysis from the Cell Therapy Consortium
Authors: Peter A Riedell, Connor Grady, Loretta J. Nastoupil, Alejandro Luna, Nausheen Ahmed, Richard T Maziarz, Marie Hu, Jamie Brower, Wei-Ting Hwang, Stephen J Schuster, Andy Chen, Olalekan O. Oluwole, Veronika Bachanova, Joseph P McGuirk, Miguel-Angel Perales, Michael R. Bishop, David L. Porter
Journal: Blood (2023)
The Atypical Protein Kinase WNK1 Controls Leukemia Progression in TAL/LMO T-Cell Acute Lymphoblastic Leukemia
Authors: Anna Montanaro, Anna D'Antuono, Lucas Moron Dalla Tor, Pietro Andrei, Filippo Cavazzini, Elisa Cerretani, Federica Vento, Elisa Simoncini, Andrea Gherli, Raffaella Zamponi, Bruno Lorusso, Giannalisa Todaro, Mariateresa Giaimo, Roberta La Starza, Cristina Mecucci, Gabriella Sammarelli, Matteo Marchesini, Luca Pagliaro, Giovanni Roti
Journal: Blood (2023)
Outcomes of Patients Undergoing Fludarabine and Melphalan-Based Conditioning with Post-Transplant Cyclophosphamide for Peripheral Blood Stem Cell Allogeneic Hematopoietic Cell Transplant: Donor Type Effect
Authors: Tamer Othman, Paul B. Koller, Dongyun Yang, Sally Mokhtari, Amanda Blackmon, Vaibhav Agrawal, Hoda Pourhassan, Brian J. Ball, Idoroenyi Amanam, Shukaib Arslan, Salman Otoukesh, Karamjeet S. Sandhu, Ibrahim Aldoss, Haris Ali, Amandeep Salhotra, Ahmed Aribi, Andrew Artz, Yazeed Samara, Pamela S. Becker, Vinod Pullarkat, Forest Marc Stewart, Eileen Patricia Smith, Anthony Stein, Guido Marcucci, Stephen J. Forman, Ryotaro Nakamura, Monzr M. Al Malki
Journal: Blood (2023)
Novel Protacs Demonstrate Dual Kinase Inhibition and Degradation of HCK and BTK, and Are Highly Active in MYD88 Mutated WM and ABC DLBCL Cells
Authors: Shirong Liu, John M Hatcher, Amanda Kofides, Alexa G Canning, Jinhua Wang, Xia Liu, Nickolas Tsakmaklis, Maria Luisa Guerrera, Christopher J Patterson, Zachary R Hunter, Shayna R Sarosiek, Jorge J. Castillo, Sara J. Buhrlage, Steven P Treon
Journal: Blood (2023)
Proposal ofmyeloid Neoplasms with <i>MYC</i>-Positive Double Minutes As a Distinct Entity
Authors: Isolde Summerer, Wencke Walter, Manja Meggendorfer, Torsten Haferlach, Frank Dicker, Stephan Hutter, Niroshan Nadarajah, Constance Regina Baer, Anna Stengel, Wolfgang Kern, John M. Bennett, Claudia Haferlach, Christian Pohlkamp
Journal: Blood (2023)
Long-Term Efficacy of a 6-Month Regimen of Rituximab and Lenalidomide in Follicular Lymphoma Patients in Need of First Therapy: Updated Analysis of the SAKK 35/10 Randomized Trial
Authors: Emanuele Zucca, Saemi Schaer, Anna Vanazzi, Bjørn Østenstad, Ulrich Mey, Daniel Rauch, Björn E. Wahlin, Felicitas Hitz, Micaela Hernberg, Ann-Sofie Johansson, Peter de Nully Brown, Hans Hagberg, Andrés José María Ferreri, Fatime Krasniqi, Michèle Voegeli, Urban Novak, Thilo Zander, Hanne Bersvendsen, Christoph Mamot, Walter Mingrone, Anastasios Stathis, Stefan Dirnhofer, Stefanie Hayoz, Eva Kimby
Journal: Blood (2023)
The Prognostic Impact of Measurable Residual Disease Dynamics in Mantle Cell Lymphoma
Authors: Yanshan Huang, Yuting Yan, Ying Yu, Li Yuxi, Rui Lv, Tingyu Wang, Wenjie Xiong, Qi Wang, Wei Liu, Gang An, Weiwei Sui, Yan Xu, Wenyang Huang, Dehui Zou, Lugui Qiu, Shuhua Yi
Journal: Blood (2023)
Outcomes in Mantle Cell Lymphoma with Central Nervous System Involvement - a Dual Center Study
Authors: Nicole McLaughlin, Ashlee Joseph, Yucai Wang, Levi D. Pederson, Susan M. Geyer, Thomas E. Witzig, Andrew D. Zelenetz, J. C. C Villasboas, Michael Scordo, Paul A. Hamlin, N. Nora Bennani, Ariela Noy, Gita Thanarajasingam, Grzegorz S. Nowakowski, Luis Porrata, Carrie Thompson, Ivana Micallef, Patrick B Johnston, Thomas M. Habermann, Stephen M Ansell, Anita Kumar, Jonas Paludo
Journal: Blood (2023)
Loss of Mir-221/222 Cluster Expression Results in Short-Term Disease Progression and Poor Post-Treatment Outcome in Multiple Myeloma
Authors: Konstantinos Soureas, Christos Minopoulos, Maria-Alexandra Papadimitriou, Panagiotis Malandrakis, Panagiotis Adamopoulos, Ioannis Ntanasis-Stathopoulos, Aristea-Maria Papanota, Maria Gavriatopoulou, Diamantis C Sideris, Efstathios Kastritis, Meletios Athanasios Dimopoulos, Andreas Scorilas, Evangelos Terpos, Margaritis Avgeris
Journal: Blood (2023)
Early Identification of <i>TP53</i> mutation in Myelodysplastic Neoplasms and Acute Myeloid Leukemia Via Point-of-Care p53 Immunohistochemistry
Authors: Shyam Ajay Patel, Salwa Khedr, Sri Nuvvula, Bruce Woda, Jan Cerny, William Selove, Lloyd Hutchinson, Jonathan M. Gerber
Journal: Blood (2023)
Infection Outcomes and Hypogammaglobulinemia in Patients with Non-Hodgkin Lymphoma Treated with Immunoglobulin Replacement Therapy
Authors: Jacob Soumerai, Zaid Yousif, Thais Gift, Raj Desai, Lynn Huynh, Caitlin Haven, Mei Sheng Duh, Marie Sanchirico
Journal: Blood (2023)
Genomic Landscape of Pediatric Non-Down's Syndrome Acute Megakaryoblastic Leukemia in China
Authors: Kefei Wu, Hui Liu, Yangyang Xie, Yuhan Liu, Bowen Cui, Jiaoyang Cai, Ronghua Wang, Yong Wang, Xiang Wang, Xiaoxiao Chen, Shuang Zhao, Ting Liu, Han Wang, Wenyan Wu, Huiying Sun, Jian'an Rao, Lan Wang, Jing Chen, Jing Chen, Benshang Li, Yu Liu, Wenting Hu, Shuhong Shen
Journal: Blood (2023)
3rd-Generation Tyrosine Kinase-Inhibitors and Azacitidine Are Safe and Effective in Myeloid Blast-Phase Chronic Myeloid Leukaemia and Result in a High Proportion of Subjects in 2 nd Chronic Phase Able to Receive a Transplant
Authors: Mei Bao, Xiang Wang, Xiao-shuai Zhang, Zong-ru Li, Robert Peter Gale, Xiao-jun Huang, Qian Jiang
Journal: Blood (2023)
Circulating Tumor DNA Analysis Associates with Progression-Free Survival (PFS) with Odronextamab Monotherapy in Relapsed/Refractory (R/R) Follicular Lymphoma (FL) and Diffuse Large B-Cell Lymphoma (DLBCL): Identification of Minimal Residual Disease Status and High-Risk Subgroups from the Phase 2 ELM-2 Study
Authors: Jon E. Arnason, Jurriaan Brouwer-Visser, Stefano Luminari, David Tucker, Tae Min Kim, Won Seog Kim, Laura Magnano, Dylan Sun, Jessica Cai, Kamil Cygan, Srikanth Ambati, Hesham Mohamed, Aafia Chaudhry, Vladimir Jankovic
Journal: Blood (2023)
Donor Hemoglobin Genotype Does Not Impact Outcomes Following Matched Related Donor Hematopoietic Cell Transplantation for Sickle Cell Disease: A STAR Study
Authors: Elizabeth Stenger, Tami D. John, Deepak Chellapandian, Rikin Shah, Scott Gillespie, Yijin Xiang, Katie Liu, Monica Bhatia, Gregory M.T. Guilcher, Jennifer Jaroscak, Kimberly A. Kasow, Jennifer Krajewski, Alexander I. Ngwube, Hemalatha G. Rangarajan, John T. Horan, Lakshmanan Krishnamurti, Shalini Shenoy, Allistair Abraham
Journal: Blood (2023)
Immune Graft Composition Is Important for Deepening Response and Outcome after Autologous Stem Cell Transplantation in Patients with Multiple Myeloma Who Do Not Receive Maintenance Therapy
Authors: Yeasung Lee, Francesca Bladt, Dimitrios Leonardos, Chira Mustafa, Alexia Katsarou, Maria Atta, Marco Bua, Ian Gabriel, Jose Ros-Soto, Alexandra Bazeos, Jiri Pavlu, Sandra Loaiza, Emma Bray, Farah O'Boyle, Elisabet Nadal, Richard Szydlo, Nicholas Crump, Anastasios Karadimitris, Aristeidis Chaidos
Journal: Blood (2023)
Zilovertamab Vedotin (MK-2140) in Relapsed or Refractory Diffuse Large B-Cell Lymphoma (DLBCL): Updated Results from the Phase 2 Waveline-004 Study
Authors: Muhit Ozcan, Fangfang Lv, Lalita Norasetthada, Ewa Paszkiewicz-Kozik, Joaquin Díaz Schmidt, Dipenkumar Modi, Alexander Fosså, Sagun Goyal, Won Seog Kim, Seung Tae Lee, Armando Santoro, Mehmet Sonmez, Kumudu Pathiraja, Nishitha Reddy, Patricia Marinello, Yuqin Song
Journal: Blood (2023)
Outcomes of Attenuated Dose Fludarabine and Melphalan Based Conditioning Regimen in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplant for Acute Leukemia and Myelodysplastic Syndrome
Authors: Anmol Baranwal, Radowan Elnair, Kimberly J Langer, Rami Basmaci, Jade Kutzke, Gabriel Bartoo, Robert C Wolf, Mehrdad Hefazi, Abhishek A Mangaonkar, Mithun V Shah, Mark R. Litzow, William J. Hogan, Hassan Alkhateeb
Journal: Blood (2023)
Impact of Long-Term Treatment with Belantamab Mafodotin on Safety and Efficacy Outcomes in Patients with Relapsed/Refractory Multiple Myeloma in DREAMM-3
Authors: Vania T.M Hungria, Katja Weisel, Atanas Radinoff, Sosana Delimpasi, Gabor Mikala, Tamas Masszi, Jian Li, Marcelo Capra, Angelo Maiolino, Vasiliki Pappa, Dominik Chraniuk, Iurii Osipov, Xavier Leleu, Michael Low, Morio Matsumoto, Mary Li, Neal Sule, Margaret Polinkovsky, Randy Davis, Shelley Bright, Astrid McKeown, Joanna Opalinska, Meletios Athanasios Dimopoulos
Journal: Blood (2023)
Phenotypic and Proteomic Characterization of the Human Erythroid Progenitor Continuum Reveal Dynamic Changes in Cell Cycle and in Metabolic Pathways
Authors: Julien Papoin, Hongxia Yan, Marjorie Leduc, Morgane le-Gall, Anupama Narla, Laurie A. Steiner, Patrick G Gallagher, Christopher D. Hillyer, Emilie-Fleur Gauthier, Mohandas Narla, Lionel Blanc
Journal: Blood (2023)
Free from Drug Therapy in Multiple Myeloma (FREEDMM): MRD-Based Cessation of Maintenance
Authors: Ana Maria Avila Rodriguez, Danny Hadidi, Craig C. Hofmeister, John Quigley, Maria Zappia, Maxim Frolov, Elizaveta Benevolenskaya, Matias Eugenio Sanchez, Shrihari Kadkol, Douglas Sborov, Damiano Rondelli, Chukwuemeka Uzoka, Karen Sweiss
Journal: Blood (2023)
Durable Efficacy and Manageable Safety in Patients Age ≥ 75 Years with Relapsed/Refractory Large B-Cell Lymphoma Treated with Tisagenlecleucel in the Real-World Setting
Authors: Daniel J. Landsburg, Michael Heim, Amy Moskop, Stephen Ronan Foley, Brian T. Hill, Grant Schofield, Caron Jacobson, Samantha M. Jaglowski, Frederick L. Locke, Ron Ram, Peter A Riedell, Gunjan L. Shah, Leslie L. Popplewell, Ranjan Tiwari, Stephen Lim, Harald Jakob Maier, Marta Majdan, Marcelo Pasquini, Matthew J Frigault
Journal: Blood (2023)
Genome-Wide CRISPR/Cas9 Knock-out Screen Identifies Apoptosis-Relevant Genes in Multiple Myeloma
Authors: Clara Leticia Andersson-Rusch, Ingrid Quist-Løkken, Pål Sætrom, Vidar Beisvåg, Milosz Rolinski, Per Arne Aas, Barbara van Loon, Toril Holien
Journal: Blood (2023)
Combining Menin and MEK Inhibition to Target Poor Prognostic <i>KMT2A</i>-Rearranged RAS Pathway-Mutant Acute Leukemia
Authors: Nastassja Scheidegger, Gabriela Alexe, Delan Khalid, Rhonda E Ries, Jim Wang, Todd A. Alonzo, Jennifer Perry, Scott A Armstrong, Soheil Meshinchi, Yana Pikman, Kimberly Stegmaier
Journal: Blood (2023)
An Unsupervised Machine Learning Method Stratifies Chronic Lymphocytic Leukemia Patients into Novel Categories with Different Risk of Early Treatment
Authors: Federico Pozzo, Francesca Cuturello, Edith Villegas Garcia, Francesca Rossi, Massimo Degan, Paola Nanni, Ilaria Cattarossi, Eva Zaina, Paola Varaschin, Alessandra Braida, Michele Berton, Laura Zannier, Filippo Vit, Erika Tissino, Tamara Bittolo, Roberta Laureana, Giovanni Francesco D'Arena, Luca Laurenti, Agostino Tafuri, Jacopo Olivieri, Francesco Zaja, Annalisa Chiarenza, Francesco Di Raimondo, Maria Ilaria Del Principe, Riccardo Bomben, Antonella Zucchetto, Alessio Ansuini, Chris Fegan, Chris Pepper, Andrea Pepper, Kari G. Rabe, Sameer A. Parikh, Neil E. Kay, Alberto Cazzaniga, Valter Gattei
Journal: Blood (2023)
A Patient-Centric Registry Dataset Generates Real-World Insights about Cause, Timing, Type, and Impact of Cardiotoxic Adverse Events in Chronic Lymphocytic Leukemia
Authors: Hana E. Littleford, Nivita Singh-Bulkan, Melissa Bacchus, MHS, PA-C, Joseph Kim, Richard L. Martin, Alix M.B. Lacoste, Elise Brimble, Conner O'Brien, Larry A. Saltzman, Lee M. Greenberger, Amanda Nottke
Journal: Blood (2023)
Tranexamic Acid to Prevent Bleeding in Patients with Hematologic Malignancies and Severe Thrombocytopenia (TREATT trial). a Randomized Placebo-Controlled Trial
Authors: Lise J Estcourt, Zoe K McQuilten, Peter Bardy, Merrole Cole-Sinclair, Graham P. Collins, Philip J Crispin, Jennifer Curnow, Amber Degelia, Claire Dyer, Vanessa Fox, Adam Friebe, Lajos Floro, Effie Grand, Cara Hudson, Gail Jones, Joanne Joseph, Charlotte Kallmeyer, Marina Karakantza, Paul Kerr, Sara Last, Maria Lobo-Clarke, Matthew Lumley, Mary Frances McMullin, Patrick G. Medd, Suzy M Morton, Andrew David Mumford, Maria Mushkbar, Joe Parsons, Gillian Powter, Mallika Sekhar, Richard Soutar, William S. Stevenson, Elango Subramoniapillai, Robyn Sutherland, Jeff Szer, Neil A Waters, Andrew H. Wei, David Alan Westerman, Sarah A Wexler, Erica M. Wood, Simon J Stanworth
Journal: Blood (2023)
Reduction of Metabolic Active Tumor Volume Prior to CAR T-Cell Therapy Improves Survival Outcomes in Patients with Large B-Cell Lymphoma
Authors: Kylie Keijzer, Janneke W. de Boer, Jaap A. van Doesum, Walter Noordzij, Gerwin A. Huls, Lisanne V. van Dijk, Tom van Meerten, Anne G.H. Niezink
Journal: Blood (2023)
Mitochondrial dsRNA from B-Precursor Acute Lymphoblastic Leukemia Cells Induce Formation of Cancer Associated Fibroblast in the Bone Marrow Leading to Formation of a Chemoprotective Bone Marrow Niche
Authors: Aditi Dey, Richard Burt, Emily Annie Cutler, Hermione Elsie Allen, Jenny Chatzigerou, Rodothea Amerikanou, Samantha Atkinson, Ashish Dhir, Kristina Kirschner, Adele Kay Fielding
Journal: Blood (2023)
New Onset Neurocognitive Impairment in Long-Term Survivors of Early Adolescent and Young Adult Hematologic Malignancies: A Report from the Childhood Cancer Survivor Study
Authors: Amy Yuan Wang, Annalynn M Williams, Yan Chen, Yutaka Yasui, Wendy Stock, Wendy Leisenring, Gregory Armstrong, Kevin Oeffinger, Eric J. Chow, Kevin R. Krull, Tara O. Henderson
Journal: Blood (2023)
Time to Lymphoma Treatment within 24 Months in Watchful Waiting Follicular Lymphoma Defines Patients at High Risk for Progression: A Multicenter Analysis
Authors: Fenghua Gao, Jing Liu, Jiesong Wang, Lihong Liu, Zhiming Li, Yuqin Song, Xudong Zhang, Hui Zhou, Xiuhua Sun, Wei Zhang, Bing Xu, Liping Su, Wen Shujuan, Rong Tao, Ou Bai, Qingyuan Zhang, Liqun Zou, Xianhuo Wang, Huilai Zhang
Journal: Blood (2023)
Ex Vivo Enriched Tumor Antigen-Specific T Cells Are Optimal Effectors of T Cell Engagers and Tumor-Specific T Cell Receptor/T Cell Engager Combination Provides Synergistic Efficacy Against Hematologic Malignancies
Authors: Manpreet Bariana, Mark Batistick, Mathias Oelke, Sojung Kim, Elena Cassella, Sidharth Anand, Shaina Anuncio, Ashley Varkey, Ruipeng Wang, Jack Ragheb, David Siegel, Johannes Zakrzewski
Journal: Blood (2023)
Genetic and Functional Characterization of <i>NUP98</i>-Rearranged Leukemia
Authors: Masayuki Umeda, Nicole Michmerhuizen, Ryan Hiltenbrand, Juan Barajas, Bright Arthur, Michael P Walsh, Guangchun Song, Jing Ma, Tamara Westover, Cristina Mecucci, Danika Di Giacomo, Franco Locatelli, Riccardo Masetti, Salvatore Bertuccio, Martina Pigazzi, Ilaria Iacobucci, Charles G. Mullighan, Jeffery M. Klco
Journal: Blood (2023)
Ibrutinib and Rituximab Versus Fludarabine, Cyclophosphamide, and Rituximab for Patients in NCRI FLAIR Study with Previously Untreated CLL: Assessment of Mutational Landscape of Patients at Baseline and Prognostic Impact
Authors: Surita Dalal, Anita Sarma, Jane Shingles, Paul Glover, Helen Warren, Thomas Grand, Nichola Webster, Andy Rawstron, Darren Newton, Sue Bell, David Allan Cairns, Sean Girvan, Natasha Greatorex, Anna Hockaday, Sharon Jackson, David Phillips, David Stones, David Allsup, Adrian John Clifton Bloor, Abraham Mullasseril Varghese, Talha Munir, Peter Hillmen
Journal: Blood (2023)
Stem Cell Utilization in the Era of Novel Therapies for Multiple Myeloma
Authors: Noriko Nishimura, David Nemirovsky, Sean M. Devlin, Parastoo B. Dahi, Heather Landau, Oscar Boutros Lahoud, Michael Scordo, Gunjan L. Shah, Sham Mailankody, Hani Hassoun, Kylee H Maclachlan, Malin Hultcrantz, Neha Korde, Alexander Lesokhin, Urvi A Shah, Carlyn Tan, Gaurav Gupta, Elena Maryamchik, Rugved Pattarkine, Grace Linder, Saad Z Usmani, Sergio A. Giralt, David Chung
Journal: Blood (2023)
Bellwave-010: Phase 3, Open-Label, Randomized Study of Nemtabrutinib Plus Venetoclax Versus Venetoclax Plus Rituximab in Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma Following at Least One Prior Therapy
Authors: David Lavie, Muhit Ozcan, Arvind Chaudhry, Xuan Zhou, Ima Paydar, Mohammed Z.H. Farooqui, Paolo Ghia
Journal: Blood (2023)
DNA Methylation Changes in Nucleated Red Blood Cells from Patients with Sickle Cell Disease: A Potential Marker of Engraftment after Stem Cell Transplantation
Authors: Jasmine Lewis, Nicolas Prud'homme, Ellen Kennedy, Fatima Iqbal, Amit Kalra, Pauline de Jesus, Gurpreet Singh, Monica Bhatia, Faisal Khan, Steven C. Greenway, Gregory M.T. Guilcher
Journal: Blood (2023)
iPSC-Derived Dual Antigen Receptor T Cells Targeting GD2 and LMP2 Antigens for Extranodal NK/T-Cell Lymphoma, Nasal Type
Authors: Shintaro Kinoshita, Midori Ishii, Yoshiki Furukawa, Shoko Sato, Jun Ando, Hiromitsu Nakauchi, Miki Ando
Journal: Blood (2023)
Development of a Regulated, Optimized Mesothelin Chimeric Antigen Receptor (CAR) for the Treatment of Mesothelin Positive Cancers
Authors: Jason Yokoyama, Allan Wang, Maria Steele, John Crowl, Thaddeus Davenport, Jared Hammer, Willimark Obenza, Vanessa Montoya, Robin Kirkpatrick, Laura Baker, Tina Tan, Emily Bringgold, Kristie Shirley, Maanasee Deshmukh, Bradley Hammerson, Paul Sample, Brian Weitzner, Shujun Yuan, Aaron Foster, Marc Lajoie, Scott Boyken, Howell Moffett, Rupesh Amin
Journal: Blood (2023)
Preliminary Safety, Pharmacokinetics, Pharmacodynamics and Clinical Activity of KT-333, a Targeted Protein Degrader of STAT3, in Patients with Relapsed or Refractory Lymphomas, Large Granular Lymphocytic Leukemia, and Solid Tumors
Authors: Aditi Shastri, Eric J Feldman, Alexander N Starodub, Tatyana Feldman, Cristina P Rodriguez, Zachary D. Epstein-Peterson, Don A. Stevens, Adam J Olszewski, Auris O Huen, Pierluigi Porcu, John C Reneau, Stefan K. Barta, Enrica Marchi, Ahmad H Mattour, Lauren C. Pinter-Brown, Rachelle Perea, Sean Donohue, Joyoti Dey, Sagar Agarwal, Rahul Karnik, Ashwin Gollerkeri, Jared Gollob, Stephen D Smith
Journal: Blood (2023)
A Comparison of Bleeding Events Among Patients on Apixaban, Rivaroxaban, and Warfarin for Atrial Fibrillation and/or Venous Thromboembolism
Authors: Jordan K Schaefer, Josh Errickson, Xiaowen Kong, Mona A Ali, Naina Chipalkatti, Brian Haymart, Scott Kaatz, Gregory D Krol, Suman L Sood, James Froehlich, Geoffrey D. Barnes
Journal: Blood (2023)
An <i>In Vivo</i> <i>PiggyBac</i> Insertional Mutagenesis Screen Reveals Oncogenic Lesions Cooperating with <i>Myd88 L265P</i>
Authors: Svenja Höfmann, Ruth Flümann, Julia Hansen, Sebastian Klein, Jörn Meinel, Pauline Pfeiffer, Hannah Goldfarb-Wittkopf, Anna Lütz, Jessica Wirtz, Michael Möllmann, Tanja Zhou, Areya Tabatabai, Tim Lohmann, Filippo Beleggia, Benedikt Pelzer, Fabian Ullrich, Aastha Arora, Thorsten Persigehl, Reinhard Büttner, Bastian von Tresckow, Ron Jachimowicz, Gero Knittel, Hans Christian Reinhardt
Journal: Blood (2023)
Progression-Free Survival but Not Overall Survival Is Superior in Relapsed/Refractory Large B-Cell Lymphomas Treated with Axicabtagene Ciloleucel Compared to Tisagenlecleucel: Results of the CART-SIE Real Life Italian Study
Authors: Annalisa Chiappella, Anna Dodero, Beatrice Casadei, Chiara De Philippis, Silva Ljevar, Eugenio Galli, Alice Di Rocco, Matteo Giovanni Carrabba, Maria Chiara Tisi, Maurizio Musso, Ilaria Cutini, Anna Maria Barbui, Mirko Farina, Massimo Martino, Anna Guidetti, Barbara Botto, Giovanni Grillo, Jacopo Olivieri, Martina Pennisi, Mauro Krampera, Marco Ladetto, Massimo Massaia, Luca Arcaini, Federica Cavallo, Rosalba Miceli, Maurizio Martelli, Patrizia Chiusolo, Stefania Bramanti, Pier Luigi Zinzani, Paolo Corradini
Journal: Blood (2023)
Effects of Antibiotic Eradication Therapy on <i>H. Pylori</i>-Negative Stage IE Gastric MALT Lymphoma ─ Real World Experience
Authors: Chonlada Laoruangroj, Thomas M. Habermann, Rebecca L. King, Scott Lester, Carrie Thompson, Yucai Wang, Thomas E. Witzig
Journal: Blood (2023)
Spatial Transcriptomics Reveals Distinct Hematopoietic Stem Cell Niches in Mouse Fetal Liver
Authors: Ruochen Dong, Hua Li, Xi He, Anoja Perera, Seth Malloy, Jonathon Russell, Wenting Li, Kaitlyn Petentler, Xinjian Mao, Zhe Yang, Michael Epp, Kate Hall, Allison Scott, Sarah Smith, Mark Hembree, Yongfu Wang, Sean McKinney, Jeff Haug, Jay Unruh, Brian Slaughter, Linheng Li
Journal: Blood (2023)
ELTD1 Suppression Enhances Human Embryonic Stem Cell Hematopoiesis By Facilitating Hemogenic Endothelial Progenitor Induction Via Wnt/β-Catenin Signaling Inhibition
Authors: Qian Luo, Honghu Li, Yijin Chen, Hengwei Wu, Yi Luo, Meng Zhang, He Huang
Journal: Blood (2023)
Brexucabtagene Autoleucel in Adults with Relapsed/Refractory B-Cell ALL: Outcomes and Novel Insights from the Real-World Outcomes Collaborative of CAR T in Adult ALL (ROCCA)
Authors: Gregory W Roloff, Ibrahim Aldoss, Noam E. Kopmar, Chenyu Lin, Simone E. Dekker, Vishal K Gupta, Nikeshan Jeyakumar, Timothy E O'Connor, Amy Zhang, Katharine Miller, Kaitlyn C Dykes, Mohamed Ahmed, Hector Zambrano, Danielle Bradshaw, Santiago Mercadal, Marc Schwartz, Sean Tracy, Bhagirathbhai Dholaria, Michal Kubiak, Akash Mukherjee, Navneet Majhail, Minoo Battiwalla, Luke Mountjoy, Shahbaz A. Malik, John Mathews, Paul Shaughnessy, Aaron C. Logan, Abdullah Ladha, George Yaghmour, Anjali S. Advani, Maryann Stefan, Caitlin Guzowski, Rasmus T. Hoeg, Talal Hilal, Jozal Moore, Kristen M. O'Dwyer, Stephanie B. Tsai, Joshua Sasine, Melhem M. Solh, Catherine J. Lee, Vamsi K. Kota, Divya Koura, Muthu Veeraputhiran, Betsy Blunk, Jessica T. Leonard, Veronika Bachanova, Wendy Stock, Ahmed Galal, Vinod Pullarkat, Ryan D Cassaday, Bijal D. Shah, Rawan Faramand, Lori S. Muffly
Journal: Blood (2023)
Blood Count Recovery and Telomere Elongation in a <i>TINF2</i> Patient Under Treatment with a Gonadotropin-Releasing Hormone (GnRH) Agonist
Authors: Fernanda Gutierrez-Rodrigues, Natthakan Thongon, Christopher L Williams, Simona Colla, Neal S. Young, Alison A. Bertuch
Journal: Blood (2023)
T-Cells Immune Cluster Analysis Using Cytof Identifies Unique Patient Subgroups with <i>TP53</i> Mutation and Predicts Complete Remission (CR) in Patients with Acute Myeloid Leukemia (AML) Receiving Venetoclax Plus Hypomethylating Agent Therapy
Authors: Talha Badar, Keith Knutson, James M. Foran, Naseema Gangat, Kevin Pavelko, Scott H. Kaufmann, Mark R. Litzow, Hemant S. Murthy, Davitte Cogen, Margaret Ushman, Arini Arsana, Aref Al-Kali, Hassan Alkhateeb, Ayalew Tefferi, Mrinal M. Patnaik, Mithun V Shah
Journal: Blood (2023)
Acalabrutinib with Rituximab As First-Line Therapy for Older Patients with Mantle Cell Lymphoma - a Phase II Clinical Trial
Authors: Preetesh Jain, Chi Young OK, Loretta J. Nastoupil, Jason Westin, Holly A Hill, Ranjit Nair, Swami P. Iyer, Ahmed Fetooh, Hun Ju Lee, Sairah Ahmed, Rashmi Kanagal-Shamanna, Fatima Z Jelloul, Luis Enrique Malpica Castillo, Yang Liu, Yijing Li, Jovanny Vargas, Lei Feng, Maria Badillo, Selvi Thirumurthi, Guofan Xu, Anita Deswal, Cezar Iliescu, Vinh Quang Nguyen, Guilin Tang, Keyur P. Patel, Francisco Vega, L. Jeffrey Medeiros, Michael L. Wang, Christopher R. Flowers
Journal: Blood (2023)